Wave Life Sciences WVE Enterprise value

Enterprise value at other companies

Eli LillyLLY

$1.12T+51.8%

Sarepta Therapeutics, Inc.SRPT

$1.52B-2.9%

Ionis PharmaceuticalsIONS

$13.02B+91.2%

Madrigal Pharmaceuticals, Inc.MDGL

$12.46B+98.7%

ALN

Alnylam PharmaceuticalsALNY

$38.74B-6.7%

Beam TherapeuticsBEAM

$2.39B+51.2%

FAQ

What is Wave Life Sciences's enterprise value?

Wave Life Sciences (WVE) reported enterprise value of $793.44M in Q2 2026.

How has Wave Life Sciences's enterprise value changed year-over-year?

Wave Life Sciences's enterprise value decreased by 9.4% year-over-year, from $875.72M to $793.44M.

What is the long-term trend for Wave Life Sciences's enterprise value?

Over 5 years (2020 to 2025), Wave Life Sciences's enterprise value has grown at a 52.9% compound annual growth rate (CAGR), from $307.82M to $2.57B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.